4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
批准号:
10020516
负责人:
Veerle Bergink
金额:
$28.2万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2021-03-31
关键词:
2 year oldAccelerationAddressAffectAgeAlcohol or Other Drugs useAssessment toolAttitudeBehavioralBiologicalBirthBrainCharacteristicsChildChildhoodCognitiveCollectionCommunitiesComplexDataData CollectionData QualityData SetDevelopmentDisadvantagedDropoutDropsEarly InterventionElectroencephalographyElementsEmotionalEnrollmentEnvironmental Risk FactorEthnic OriginEvaluationExposure toFamilyFathersFetal DevelopmentFetusFoundationsGoalsHealth SciencesHumanImageImage AnalysisInfantInfant HealthInstitutesInvestigationKnowledgeLeadLearningLinkLogisticsLong-Term EffectsLongitudinal StudiesLongitudinal SurveysLongitudinal cohort studyLongitudinal prospective studyMagnetic Resonance ImagingMeasurementMeasuresMedical centerMeta-AnalysisMethodologyMethodsModelingMonitorMotionMovementNeonatalNeonatal Abstinence SyndromeNew YorkNew York CityOpiate AddictionOpioidOpioid userOregonOutcomeParticipantPatientsPersonal SatisfactionPersonsPhasePopulationPopulation StudyPositioning AttributePregnancyPregnant WomenProbabilityProspective cohort studyProtocols documentationPsychosocial Assessment and CareRaceRecording of previous eventsResearchResearch DesignResearch PersonnelResourcesRisk FactorsRoleSavingsSiteSocioeconomic StatusStandardizationStructureTestingThird Pregnancy TrimesterTimeToddlerUltrasonographyUnited States National Institutes of HealthUniversitiesValidationVariantVermontWorkbiobehaviorcritical perioddata acquisitiondata collection methodologydata sharingdemographicsdesignearly childhoodefficacy testingexperiencefetalfetal drug exposurefetal opioid exposureflexibilityhealth assessmenthigh risk populationimprovedincentive strategiesinnovationlifestyle factorsmultidisciplinarymultimodalityneonatal magnetic resonance imagingneonateneurodevelopmentneuroimagingnovelopioid exposureopioid useopioid use in pregnancyphase 2 studypostnatalpreferencepregnantprenatalprospectiveprotective factorsrecruitresearch studyresilienceresponseretention ratesocialsuccesstoolusabilityyoung mother
中文摘要
项目总结
虽然新生儿禁欲综合症的比率在全国范围内达到了惊人的每1000名新生儿中有6.5人,但
阿片类药物暴露的短期和长期影响远不清楚。我们缺乏基本的知识
典型的新生儿神经发育和努力将阿片类药物暴露的影响与其他
影响婴儿健康的保护性因素和风险因素。胎儿时期是大脑发育的关键时期
当大脑结构和功能的基本方面建立起来的时候。此外,出生后的大脑
发展和专业化是由环境经验塑造的,因此允许成熟
受与阿片类药物使用相关的生活方式因素的影响。该项目一期规划规模大、规模大。
对人类大脑、认知、行为、社交和情感进行前瞻性研究的现场研究
从胎儿期开始直到童年的发育。纽约大学是四个相互关联的申请之一
与俄勒冈健康与科学大学、匹兹堡大学医学院的研究人员合作
佛蒙特州中心和佛蒙特州大学。我们将共同应对关键挑战,这些挑战对
计划中的第二阶段研究。目标1将开发、实施和评估创新的招聘和留用
针对高危人群的战略。我们将衡量可行性、吞吐量和人口统计
150例孕妇不同招募方式特征的纵向调查
每个地点有600名妇女(跨地点),其中一半人在怀孕期间使用阿片类药物。AIM 2将实施多个
站点,标准化的纵向研究方案,每个站点招募20名孕妇(跨站点n=80),
其中一半人在怀孕期间使用阿片类药物。这项前瞻性的纵向研究将收集胎儿和新生儿
多模式核磁共振、生物成像以及产妇心理社会和健康评估。AIM 3将评估
旨在解决关键问题的创新磁共振成像获取和处理策略和统计考虑因素
第二阶段目标,包括最佳计量战略和跨地点协调。具体来说,我们会:(A)
评估交叉扫描仪和跨时间图像协调的策略;(B)测试MRI的实时评估
采集过程中的数据质量/运动;(C)测试加速图像采集序列的效果;和(D)
建设胎儿和新生儿磁共振成像处理管道。我们的纽约调查团队广泛贡献了
对阿片成瘾患者、暴露于阿片类药物的胎儿和纵向队列的领先研究经验
研究对象为孕妇、幼儿和难以接触到的人群。我们已经执导了多部
进行了大规模的人群研究,并进行了多模式核磁共振、脑电和超声波
对胎儿、新生儿和儿童的研究。我们先前在婴儿MRI数据和纵向建模方面的专业知识
磁共振成像方法学的发展非常适合于引导AIM 3‘S图像的协调和胎儿/新生儿
加工流水线开发。此外,纽约市的人口带来了亟需的多样性
从种族、民族、原籍和社会经济地位到相互关联的协作应用程序。
英文摘要
PROJECT SUMMARY
While the rate of neonatal abstinence syndrome has reached a staggering 6.5 per 1,000 births nationwide, the
short- and long-term effects of opioid exposure are far from clear. We lack fundamental knowledge of
neurotypical neonatal development and struggle to disentangle the effect of opioid exposure from other
protective and risk factors impacting infant health. The fetal stage of brain development is a critical period
when foundational aspects of brain structure and function are being established. In addition, postnatal brain
development and specialization are shaped by environmental experiences thus allowing maturation to be
influenced by lifestyle factors associated with opioid use. This Phase I project will plan for a large scale, multi-
site research study to prospectively examine human brain, cognitive, behavioral, social, and emotional
development beginning prenatally through childhood. New York University is one of four linked applications
collaborating with investigators at Oregon Health and Sciences University, University of Pittsburgh Medical
Center and University of Vermont. Together, we will address key challenges that are critical to the success of
the planned Phase II study. Aim 1 will develop, implement and evaluate innovative recruitment and retention
strategies for high-risk populations. We will measure the feasibility, throughput, and demographic
characteristics associated with different recruitment methods through a longitudinal survey of 150 pregnant
women per site (n=600 across sites), half of whom use opioids during pregnancy. Aim 2 will implement a multi-
site, standardized, longitudinal research protocol by enrolling 20 pregnant women per site (n=80 across sites),
half of whom use opioids during pregnancy. This prospective longitudinal study will collect fetal and neonatal
multi-modal MRI, biospecimens, and maternal psychosocial and health assessments. Aim 3 will evaluate
innovative MRI acquisition and processing strategies and statistical considerations intended to address key
Phase II goals, including optimal measurement strategies and cross-site harmonization. Specifically, we will (a)
evaluate strategies for cross-scanner and cross-time image harmonization; (b) test real-time evaluation of MRI
data quality/motion during acquisition; (c) test the efficacy of accelerated image acquisition sequences; and (d)
build fetal and neonatal MRI processing pipelines. Our New York investigative team contributes extensive
experience leading studies in patients with opioid addiction, fetuses exposed to opioids, and longitudinal cohort
studies in pregnant patients, young children, and difficult to reach populations. We have directed multiple
consortia, performed large-scale population studies, and conducted multimodal MRI, EEG, and ultrasound
studies in fetuses, neonates, and children. Our prior expertise in longitudinal modelling of infant MRI data and
MRI methodology development suits us well to lead Aim 3's image harmonization and fetal/neonatal
processing pipeline development. Additionally, the New York City population brings much-needed diversity
across race, ethnicity, nativity, and socioeconomic status to the linked collaborative applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
-
批准号:10296635
-
项目类别:
-
资助金额:$77.33万
-
财政年份:2021
-
负责人:Veerle Bergink
-
依托单位:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
-
批准号:10640239
-
项目类别:
-
资助金额:$67.17万
-
财政年份:2021
-
负责人:Veerle Bergink
-
依托单位:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
-
批准号:10468261
-
项目类别:
-
资助金额:$70.9万
-
财政年份:2021
-
负责人:Veerle Bergink
-
依托单位:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
-
批准号:10569044
-
项目类别:
-
资助金额:$55.2万
-
财政年份:2020
-
负责人:Veerle Bergink
-
依托单位:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
-
批准号:10117285
-
项目类别:
-
资助金额:$54.71万
-
财政年份:2020
-
负责人:Veerle Bergink
-
依托单位:
EXPOSURE TO TETRACYCLINE ANTIBIOTICS AND THE POTENTIAL PROTECTIVE EFFECT ON SCHIZOPHRENIA RISK.
-
批准号:10039207
-
项目类别:
-
资助金额:$41.28万
-
财政年份:2020
-
负责人:Veerle Bergink
-
依托单位:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
-
批准号:10334499
-
项目类别:
-
资助金额:$55.2万
-
财政年份:2020
-
负责人:Veerle Bergink
-
依托单位:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
-
批准号:9899554
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2019
-
负责人:Veerle Bergink
-
依托单位:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
-
批准号:10321798
-
项目类别:
-
资助金额:$22.89万
-
财政年份:2019
-
负责人:Veerle Bergink
-
依托单位:
海外基金